Overview

Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans

Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
After initial eligibility screening, Veterans who use both cannabis and tobacco will be randomly assigned to receive either varenicline (Chantix) or placebo for 12 weeks. Participants will attend weekly visits to provide breath and urine samples for testing, fill out questionnaires, and meet with study staff about medication compliance.
Phase:
Phase 2
Details
Lead Sponsor:
VA Office of Research and Development
Treatments:
Varenicline